|
End-of-day quote
Korea S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 7,040.00 KRW | -3.03% |
|
+1.73% | -56.81% |
| 05-19 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 27/05/25 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
| Market Cap | 56.37B 42.26M 37.85M 34.81M 31.54M 58.97M 4.01B 60.07M 415M 167M 2.11B 159M 155M 6.66B | P/E 2024 |
29.9x | P/E 2025 | -18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 21.08B 15.81M 14.16M 13.02M 11.8M 22.05M 1.5B 22.47M 155M 62.33M 789M 59.32M 58.06M 2.49B | EV / Sales 2024 |
11x | EV / Sales 2025 | 16x |
| Free-Float |
51.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.03% | ||
| 1 week | +1.73% | ||
| Current month | -3.30% | ||
| 1 month | -3.30% | ||
| 3 months | +19.73% | ||
| 6 months | -43.45% | ||
| Current year | -56.81% |
| 1 week | 6,620 |  | 7,540 |
| 1 month | 6,310 | | 7,540 |
| Current year | 5,230 | | 16,500 |
| 1 year | 5,230 | | 18,500 |
| 3 years | 5,230 | | 26,100 |
| 5 years | 5,230 | | 26,100 |
| 10 years | 5,230 | | 73,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
CEO | Chief Executive Officer | 60 | 20/03/2001 |
Han-Kyu Jang
PRN | Corporate Officer/Principal | 54 | - |
Sung-In Chung
AUD | Comptroller/Controller/Auditor | 66 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
BRD | Director/Board Member | 60 | 20/03/2001 |
Jae-Wook Jeon
BRD | Director/Board Member | 63 | 20/03/2001 |
Han-Kyu Jang
BRD | Director/Board Member | 54 | 01/05/2001 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | +1.73% | -60.05% | -9.04% | 42.26M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.57% | +5.66% | +35.92% | +75.20% | 426.2B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.76B 5.07M 4.54M 4.17M 3.78M 7.07M 481M 7.2M 49.78M 19.99M 253M 19.02M 18.61M 798M | 5.94B 4.45M 3.99M 3.67M 3.32M 6.21M 423M 6.33M 43.76M 17.57M 222M 16.72M 16.36M 702M |
| Net income | 3.35B 2.51M 2.25M 2.07M 1.87M 3.5M 238M 3.57M 24.67M 9.9M 125M 9.43M 9.22M 396M | -7.01B -5.26M -4.71M -4.33M -3.92M -7.34M -499M -7.47M -51.65M -20.73M -263M -19.73M -19.31M -828M |
| Net Debt | -25.58B -19.18M -17.18M -15.8M -14.32M -26.76M -1.82B -27.26M -188M -75.64M -958M -71.98M -70.45M -3.02B | -35.28B -26.45M -23.69M -21.79M -19.75M -36.91M -2.51B -37.6M -260M -104M -1.32B -99.28M -97.17M -4.17B |
Employees
39
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₩7,040.00 | -3.03% | 1,156 |
| 29/10/26 | ₩7,260.00 | -1.89% | 2,742 |
| 28/10/26 | ₩7,400.00 | +6.32% | 7,892 |
| 27/10/26 | ₩6,960.00 | +2.35% | 3,125 |
| 26/10/26 | ₩6,800.00 | -1.73% | 2,281 |
- Stock Market
- Stocks
- A191420 Stock
Select your edition
All financial news and data tailored to specific country editions
